BDBM50479982 Aptivus::CHEBI:63628::TIPRANAVIR::Tipranavir::U-140690::US10806794, Compound Tipranavir
SMILES: CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(cn3)C(F)(F)F)c2)C(=O)O1
InChI Key: InChIKey=SUJUHGSWHZTSEU-FYBSXPHGSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Protease (Human immunodeficiency virus 1 (HIV-1)) | BDBM50479982![]() (Aptivus | CHEBI:63628 | TIPRANAVIR | Tipranavir | ...) | PDB UniProtKB/TrEMBL GoogleScholar | Purchase MCE PC cid PC sid PDB UniChem | PDB Article PubMed | 8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Inhibition of HIV1 protease by fluorescent peptide substrate based assay | Antimicrob Agents Chemother 51: 3147-54 (2007) Article DOI: 10.1128/aac.00401-07 BindingDB Entry DOI: 10.7270/Q23R0WPV | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
HIV-1 protease (Human immunodeficiency virus) | BDBM50479982![]() (Aptivus | CHEBI:63628 | TIPRANAVIR | Tipranavir | ...) | PDB MMDB UniProtKB/TrEMBL GoogleScholar | Purchase MCE PC cid PC sid PDB UniChem | PDB US Patent | n/a | n/a | 7.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Nektar Therapeutics US Patent | Assay Description Protease inhibitors (PI) are used to treat HIV infection by preventing viral assembly and maturation through the inhibition of HIV-1 protease activit... | US Patent US10806794 (2020) | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) |